Related Experiment Video
Updated: Oct 30, 2025

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
CircVAMP3: A circRNA with a Role in Alveolar Rhabdomyosarcoma Cell Cycle Progression
Francesca Rossi1, Alvaro Centrón-Broco1, Dario Dattilo1
1Department of Biology and Biotechnology Charles Darwin, Sapienza University of Rome, 00185 Rome, Italy.
Abstract:
Circular RNAs (circRNAs), a class of covalently closed RNAs formed by a back-splicing reaction, have been involved in the regulation of diverse oncogenic processes. In this article we describe circVAMP3, a novel circular RNA overexpressed in RH4, a representative cell line of alveolar rhabdomyosarcoma. We demonstrated that circVAMP3 has a differential m6A pattern opposed to its linear counterpart, suggesting that the two isoforms can be differently regulated by such RNA modification. Moreover, we show how circVAMP3 depletion in alveolar rhabdomyosarcoma cells can impair cell cycle progression, through the alteration of the AKT-related pathways, pointing to this non-coding RNA as a novel regulator of the alveolar rhabdomyosarcoma progression and as a putative future therapeutic target.
Insights
Researchers identified circVAMP3, a novel circular RNA (circRNA) overexpressed in alveolar rhabdomyosarcoma. Depleting circVAMP3 impairs cell cycle progression, highlighting its role in cancer and potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- RNA Biology
Background:
- Circular RNAs (circRNAs) are implicated in various oncogenic processes.
- Alveolar rhabdomyosarcoma is a pediatric cancer with limited therapeutic options.
Purpose of the Study:
- To investigate the role of circVAMP3 in alveolar rhabdomyosarcoma.
- To explore circVAMP3 as a potential therapeutic target.
Main Methods:
- Characterization of circVAMP3 expression in alveolar rhabdomyosarcoma cell lines.
- Analysis of m6A modification patterns in circVAMP3 and its linear counterpart.
- Assessment of circVAMP3's functional impact on cell cycle progression and AKT pathways upon depletion.
Main Results:
- circVAMP3 was found to be overexpressed in RH4 cells, a model for alveolar rhabdomyosarcoma.
- circVAMP3 exhibits a distinct m6A methylation pattern compared to its linear form.
- Depletion of circVAMP3 led to impaired cell cycle progression and altered AKT signaling.
Conclusions:
- circVAMP3 is a novel circular RNA regulator in alveolar rhabdomyosarcoma progression.
- circVAMP3's unique m6A modification suggests differential regulation.
- circVAMP3 represents a potential therapeutic target for alveolar rhabdomyosarcoma.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Positive Regulator Molecules

